跳至主要内容
临床试验/NCT04788758
NCT04788758已完成不适用

Feasibility of Implementation and Assessment of Geriatric Assessment Screening Tool in Outpatient Oncology Clinic

Thomas Jefferson University2 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2020年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
76
试验地点
2
主要终点
Overall assessment score: Post

研究概览

简要总结

This phase II trial investigates how easy it is to incorporate a nursing led geriatric assessment screening tool into a busy oncology practice, in order to identify at-risk older adults being evaluated for cancer treatment. This screening tool may help identify at-risk patients who can be referred for more in depth assessment, allowing for the creation of an individualized treatment plan that puts the patient's safety and personal goals as a priority.

详细描述

PRIMARY OBJECTIVE:

I. To determine the feasibility of training nurses to administer the Geriatric 8 (G8) screening tool in an oncology practice, to identify older patients (> 65 years old [y/o]) that would benefit from a more extensive Comprehensive Geriatric Assessment (CGA).

SECONDARY OBJECTIVE:

I. To report the positive predictive value of the G8 screening tool with the final frailty designation determined by the Comprehensive Geriatric Assessment completed in patients referred to the Senior Adult Oncology Center (SAOC).

OUTLINE:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • NURSES: Assigned to two designated cancer clinics at Sidney Kimmel Cancer Center (SKCC) Center City, the Renal Cell Carcinoma (RCC) and Lymphoma/myeloma clinics
  • PATIENTS: 65 years and older
  • PATIENTS: Diagnosis of cancer

排除标准

  • PATIENTS: Inability to answer or have caregiver answer questions on screening tool

结局指标

主要结局

Overall assessment score: Post

时间窗: After self-administered learning module

The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.

Number of patients screened

时间窗: Up to 30 months

Will be summarized by sample means, standard deviations and/or percentages.

Time it took to screen

时间窗: Up to 30 months

Will be summarized by sample means, standard deviations and/or percentages.

Number of completed SAOC visits

时间窗: Up to 30 months

Will be summarized by sample means, standard deviations and/or percentages.

Number of patients who refused

时间窗: Up to 30 months

Will be summarized by sample means, standard deviations and/or percentages.

Overall assessment score: Pre

时间窗: Before self-administered learning module

The score will be a number between 1-20. The responses to two questions of primary interest, assessing their comfort caring for older adults and their comfort in administering the G8 tool, will be binary measurements. The overall assessment scores from pre- and post- self-administered learning module will be compared using paired Wilcoxon test.

Number of referrals to Senior Adult Oncology Center (SAOC)

时间窗: Up to 30 months

Will be summarized by sample means, standard deviations and/or percentages.

次要结局

  • Positive predictive value of the G8(Up to 30 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

尚未招募
不适用
Phase II study on the feasibility and efficacy of consolidation with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma having achieved partial or complete remission after induction with R-PECC chemotherapy.Aggressive B-cell NHL: FL grade 3b and DLBC
NL-OMON24909Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl60
招募中
不适用
Phase II study on the feasibility and efficacy of R-DHAP + HD-MTX, combined with intrathecal rituximab, followed by autologous stem cell transplantation in patients with a recurrent aggressive B-cell lymphoma with CNS localisation.Recurrent aggressive B-cell lymphoma with CNS localisation, DLBCL, non-hodgkin lymphoma, NH
NL-OMON23427Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 7041560Fax: 010 7041028e-mail: hdc@erasmusmc.nl35
已完成
1 期
Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
NCT04289194Histocell, S.L.26
已完成
不适用
A clinical feasibility study to evaluate the effectiviness and safety of VivescOs TM as bone graft for reconstruction of intra-oral osseous defects.
NL-OMON24005Isotis, Bilthoven, the Netherlands10
Unknown
不适用
Feasibility and Acceptability of HOLOBalance Compared to Standard Care in Older Adults at Risk for FallsAccidental FallsAgingVestibular Disorder
NCT04053829King's College London120